Prior research has elucidated that IL-6 engages the JAK-STAT3 pathway, contributing to a multitude of biological processes, including inflammation and angiogenesis, and it may foster tumor progression through involvement in cancer cell phenotypes such as anti-apoptosis, proliferation, and angiogenesis. This evidence concerns the gene STAT3 and neoplasm.